Trade

with

GlaxoSmithKline PLC
(NYSE: GSK)
AdChoices
44.41
+0.78
+1.79%
After Hours :
44.41
0.00
0.00%

Open

44.60

Previous Close

43.63

Volume (Avg)

9.09M (5.28M)

Day's Range

44.37-45.04

52Wk Range

41.91-56.73

Market Cap.

104.80B

Dividend Rate (Yield )

2.59 (6.08%)

Beta

0.62

Shares Outstanding

2.40B

P/E Ratio (EPS)

13.93 (3.13)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 42.77B

    • Net Income

    • 8.77B

    • Market Cap.

    • 104.80B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 19.32

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.62

    • Forward P/E

    • 23.31

    • Price/Sales

    • 2.69

    • Price/Book Value

    • 10.60

    • Price/Cash flow

    • 11.16

      • EBITDA

      • 14.18B

      • Return on Capital %

      • 11.75

      • Return on Equity %

      • 75.85

      • Return on Assets %

      • 11.75

      • Book Value/Share

      • 6.65

      • Shares Outstanding

      • 2.40B

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.65 (8/6/2014)

      • Dividend Declaration Date

      • 7/23/2014

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 25.61

        • Credit Rating

        • A+

        • Analysts

        • 8

        • EPS Estimate

        • 1.27

        • Cashflow Estimate

        • 2.15

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -16.00

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • 19.10

          • 7.80

          • Net Income

            Q/Q (last year)

          • -37.40

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • 1.71

          • 6.10

          • Net Income

            5-Year Annual Average

          • 2.90

          • 3.73

          • Dividends

            5-Year Annual Average

          • 6.58

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 67.05

            • 69.92

            • Pre-Tax Margin

            • 23.74

            • 21.84

            • Net Profit Margin

            • 19.32

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • 71.60

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 23.50

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • 16.40

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 2.37

              • 0.32

              • Current Ratio

              • 1.11

              • 1.92

              • Quick Ratio

              • 0.68

              • 1.31

              • Interest Coverage

              • 9.52

              • 17.64

              • Leverage Ratio

              • 6.35

              • 2.03

              • Book Value/Share

              • 4.10

              • 14.72

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 13.99

                • 22.12

                • P/E Ratio 5-Year High

                • 18.17

                • 193.96

                • P/E Ratio 5-Year Low

                • 10.30

                • 87.26

                • Price/Sales Ratio

                • 2.70

                • 3.75

                • Price/Book Value

                • 10.65

                • 3.75

                • Price/Cash Flow Ratio

                • 11.16

                • 14.03

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • 81.05

                    • Dividend Date

                    • 7/23/2014

                    • Ex-Dividend Date

                    • 8/6/2014

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 75.85

                        (58.40)

                      • 17.42

                        (18.66)

                      • Return on Assets %

                        (5-Year Average)

                      • 11.75

                        (10.80)

                      • 8.45

                        (8.77)

                      • Return on Capital %

                        (5-Year Average)

                      • 21.84

                        (20.90)

                      • 12.41

                        (13.18)

                      • Income/Employee

                      • 47.78k

                      • 90.07k

                      • Inventory Turnover

                      • 1.96

                      • 2.46

                      • Asset Turnover

                      • 0.61

                      • 0.46

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      11.34B
                      Operating Margin
                      26.52
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      11.16
                      Ownership

                      Institutional Ownership

                      11.82%

                      Top 10 Institutions

                      5.93%

                      Mutual Fund Ownership

                      3.44%

                      Float

                      -

                      5% / Insider Ownership

                      -

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Dodge & Cox Stock Fund

                      •  

                        16,329,300

                      • -33.17

                      • 0.68

                      • Dodge & Cox International Stock Fund

                      •  

                        11,268,249

                      • -43.24

                      • 0.47

                      • AllianzGI NFJ Dividend Value Fund

                      •  

                        4,076,200

                      • 0.00

                      • 0.17

                      • T. Rowe Price International Grth & Inc

                      •  

                        3,367,772

                      • 0.00

                      • 0.14

                      • Vanguard PrimeCap Fund

                      •  

                        3,255,400

                      • -32.52

                      • 0.14

                      • Dodge & Cox Balanced Fund

                      •  

                        3,084,500

                      • -35.21

                      • 0.13

                      • T. Rowe Price Overseas Stock Fund

                      •  

                        3,018,713

                      • 0.73

                      • 0.13

                      • Fidelity® Series Growth & Income Fund

                      •  

                        1,982,900

                      • 8.40

                      • 0.08

                      • American Beacon Large Cap Value Fund

                      •  

                        1,669,100

                      • 86.20

                      • 0.07

                      • Fidelity® Growth & Income Portfolio

                      •  

                        1,606,822

                      • 7.09

                      • 0.07

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Dodge & Cox

                      •  

                        60,226,050

                      • -0.27%

                      • 2.51

                      • Royal Bank Of Canada

                      •  

                        14,012,351

                      • +0.06%

                      • 0.58

                      • Fisher Asset Management, LLC

                      •  

                        11,488,594

                      • +1.08%

                      • 0.48

                      • State Street Corp

                      •  

                        10,809,995

                      • -0.66%

                      • 0.45

                      • T. Rowe Price Associates, Inc.

                      •  

                        9,039,831

                      • +0.47%

                      • 0.38

                      • Merrill Lynch & Co Inc

                      •  

                        9,017,749

                      • +9.54%

                      • 0.38

                      • Renaissance Technologies Corp

                      •  

                        8,869,400

                      • +26.53%

                      • 0.37

                      • BNY Mellon Wealth Management

                      •  

                        6,383,675

                      • -1.21%

                      • 0.27

                      • Fidelity Management and Research Company

                      •  

                        6,210,354

                      • -2.29%

                      • 0.26

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Drug Manufacturers – Major

                      Type

                      Slow Growth

                      Style

                      Large Value

                      GlaxoSmithKline PLC incorporated in United Kingdom. The Company creates, discoveres, develops, manufactures and markets pharmaceutical products including vaccines, over-the-counter (OTC) medicines and health-related consumer products...more. The Company's principal pharmaceutical products include medicines in the following therapeutic areas: respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines and HIV. The Company is a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. Its Pharmaceuticals business develops and makes medicines to treat a broad ran...morege of acute and chronic diseases. Its portfolio is made up of both patent-protected and off patent medicines. Its products include treatment for Infectious Diseases, Cancer, Epilepsy, Heart Disease, Asthma and Chronic obstructive pulmonary disease, and HIV/AIDS. Its Vaccine business has approximately 900 million doses distributed to 170 countries in 2012. It produces paediatric and adult vaccines to prevent a range of infectious diseases including: Hepatitis A and B, Diphtheria, Tetanus and Whooping cough, Measles, Mumps and Rubella, Polio, Typhoid, Influenza, Bacterial Meningitis. The consumer healthcare business, markets consumer health products based on scientific innovation. Its products main categories are: Oral care, Nutritional, Total wellness, and Skin health. Its barands include Sensodyne, Panadol and Horlicks. Its drinks brands are Lucozade and Ribena. The Oral Care brands, alli and Abreva.lessless

                      Key People

                      Sir Andrew Witty

                      Director/CEO

                      Sir Christopher Charles Gent

                      Chairman of the Board/Director

                      Dr. Moncef M Slaoui PhD

                      Chairman of the Board, Divisional/Director

                      Mr. Simon Dingemans

                      CFO/Director

                      Ms. Judy C. Lewent

                      Director

                      • GlaxoSmithKline PLC

                      • 980 Great West Road

                      • Brentford, Middlesex TW8 9GS

                      • GBR.Map

                      • Phone: +44 2080475000

                      • Fax: +44 2080477807

                      • gsk.com

                      Incorporated

                      1999

                      Employees

                      99,451

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: